Liz Keegan Photo

Industry Experience

Legal Intern

Millennium Pharmaceuticals, Inc. (now Takeda Pharmaceutical Company Limited)

An accomplished transactional lawyer, Elizabeth’s valuable work with Faber clients includes research and development, licensing, and clinical matters. She frequently drafts and negotiates clinical trial and related agreements and prepares customized form agreements for domestic and international clinical studies. Elizabeth also assists clients in establishing master agreements for various services and manufacturing relationships.

experience +

experience –

Skadden, Arps, Slate, Meagher & Flom

Corporate Associate

  • Representing clients across a wide range of industries with matters pertaining to public and private mergers, stock and asset sales, the registration and sale of equity securities, securities law compliance and corporate governance matters

Millennium Pharmaceuticals, Inc. (now Takeda Pharmaceutical Company Limited)

Legal Intern

Massachusetts Superior Court

Judicial Intern

Recent Client work +


Client Agreements

  • Representation of privately held pharmaceutical company in the negotiation of a Material Transfer Agreement for pre-clinical research with US academic institution
  • Research Collaboration Agreement between client and academic institution for client’s funding of research regarding CAR T-cell therapy
  • Sponsored Research Agreement to explore the activity of client compound on biological samples with specified drug resistance mutations
  • Negotiated agreement for investigator-sponsored study with large US hospital for which client provided product and funding
  • Saas Agreement for access and use by client of cloud-based software application for use in client’s clinical trial
  • Assisted with the negotiation of a Research Collaboration Agreement and Exclusive Patent License Agreement between client and US academic institution for the transfer of intellectual property rights for the development of new therapeutics

Clinical Trials

  • 4D Molecular Therapeutics Phase 1/2 Trial evaluating 4D-310, a gene replacement therapy for the treatment of Fabry disease and its Phase 1/2 Trial evaluating 4D-125, a gene replacement therapy for X-linked retinitis pigmentosa (XLRP)
  • Representation of multiple clients in negotiations of Master Services Agreements with contract research organizations for client clinical trials in North America, Asia, Europe and Australia

Community +

Community –

Elizabeth generously donates her time to several philanthropic causes, including Special Olympics, Open Heart Kitchen, Cake4kids, Valley Children’s Museum, Tri- Valley Haven and Valley Humane Society.

Bar Admissions
  • California
  • Massachusetts
  • ‍Northeastern University School of Law, J.D.
  • Colby College, B.A.